Guarner et al., 2010 - Google Patents
Consensus statements from the Workshop “Probiotics and Health: Scientific evidence”Guarner et al., 2010
View PDF- Document ID
- 14288464622577965590
- Author
- Guarner F
- Requena T
- Marcos A
- Publication year
External Links
Snippet
[EN]: This report shows the level of scientific consensus on definition, characteristics and health benefits of probiotics. The content of the report has derived from the scientific meeting: Workshop on Probiotics and Health. Scientific evidence, that congregated several …
- 230000000529 probiotic 0 title abstract description 41
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Canibe et al. | Review on preventive measures to reduce post-weaning diarrhoea in piglets | |
| EP3377082B1 (en) | Compositions comprising bacterial strains | |
| West et al. | Probiotics, immunity and exercise: a review | |
| JP6554730B2 (en) | Bifidobacterium longum and hippocampal BDNF expression | |
| Mack et al. | Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression | |
| Guarner et al. | Consensus statements from the Workshop “Probiotics and Health: Scientific evidence” | |
| JP4521687B2 (en) | Probiotics, Propionibacterium ienseni 702 | |
| ES2590916T3 (en) | Use of Lactobacillus for the treatment of virus infections | |
| ES2660813T3 (en) | New lactic acid bacteria, drug, food product or drink, and I think they contain the new lactic acid bacteria | |
| CA2772163C (en) | Bifidobacterium longum and functional gi disorders | |
| Tannock | Probiotics: time for a dose of realism | |
| AU2015100952A4 (en) | Probiotic- and enzyme-containing compositions and uses thereof | |
| Jeronymo-Ceneviva et al. | Probiotic properties of lactic acid bacteria isolated from water-buffalo mozzarella cheese | |
| Azaïs-Braesco et al. | Not all lactic acid bacteria are probiotics,… but some are | |
| CN1525863A (en) | Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria | |
| AU2010247467A1 (en) | Non-replicating micro-organisms and their immune boosting effect | |
| JP4712289B2 (en) | Immune promoting composition | |
| JPWO2019087280A1 (en) | Composition for muscle gain | |
| Kalliomäki et al. | Positive interactions with the microbiota: probiotics | |
| TW201306760A (en) | Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions | |
| JP2020164493A (en) | Composition for suppressing muscle inflammation and composition for suppressing intestinal inflammation | |
| CN111565734A (en) | Therapeutic use of lactobacillus plantarum | |
| JP2023033532A (en) | Composition for converting skeletal muscle to slow muscle | |
| Guarner et al. | Declaraciones consensuadas en el workshop" probióticos y salud: evidencia científica" | |
| JP6061530B2 (en) | NASH preventive and therapeutic agent |